Shine Justice (ASX:SHJ) NPAT up 53.6% YoY

28AugAugust 28, 2020

Shine Justice (ASX:SHJ) NPAT up 53.6% YoY

Shine Justice (ASX:SHJ) has released its financial results for the 2020 financial year.

Net profit after tax rose 53.6 per cent year on year to $21.55 million.

Underlying EBITDAI was up 10.9 per cent at $42.52 million.

Revenue saw a slight rise of 2.9 per cent to around 183 million.

The total FY20 dividend per share increased by 13.3 per cent to 4.25 cents.

Shares in Shine Justice (ASX:SHJ) are trading 7.48 per cent higher at 79 cents.

Copyright 2020 – Finance News Network

Source: Finance News Network

01JulJuly 1, 2024

Stocks of the Hour: Wellard, Infini Resources, Argent Minerals

01 Jul 2024 - A snapshot of the stocks on the move, featuring Wellard (ASX:WLD), Infini Resources (ASX:I88) and Argent Minerals (ASX:ARD).

11JunJune 11, 2021

Stocks of the Hour: Domino’s Pizza, Centuria & AMP

11 Jun 2021 - A snapshot of the top news for the hour, featuring Domino's Pizza, Centuria & AMP.

03AprApril 3, 2020

NEXTDC (ASX:NXT) complete $627 million placement

03 Apr 2020 - NEXTDC (ASX:NXT) has successfully completed an institutional placement, raising approximately $672 million through the issue of 86.1 million new shares.

23FebFebruary 23, 2023

Stocks of the Hour: Mt Monger Resources, IVE group, Dateline Resources

23 Feb 2023 - A snapshot of the stocks on the move featuring Mt Monger Resources (ASX:MTM), IVE group (ASX:IGL) and Dateline Resources (ASX:DTR).

23DecDecember 23, 2020

Ingenia Communities Group (ASX:INA) acquisition of a NSW caravan park

23 Dec 2020 - Ingenia Communities Group (ASX:INA) today announced the acquisition of Merry Beach Caravan Park for $20.5 million.

25JunJune 25, 2020

CSL (ASX:CSL) acquires a gene therapy candidate

25 Jun 2020 - CSL (ASX:CSL) has agreed to acquire from uniQure exclusive global license rights to commercialise an adeno-associated virus gene therapy program, for the treatment of haemophilia B.